Ming-Sheng Chen
Shanghai Public Health Clinical Center(CN)Tongren Hospital(CN)
Publications by Year
Research Areas
Genomics and Phylogenetic Studies, Microbial Community Ecology and Physiology, Microbial Natural Products and Biosynthesis, Plant Disease Resistance and Genetics, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Characterization and description of Faecalibacterium butyricigenerans sp. nov. and F. longum sp. nov., isolated from human faeces(2021)68 cited
- → Synthesis, characterization and in vitro anti-tumor activities of matrine derivatives(2012)45 cited
- → Cullin�7 is a predictor of poor prognosis in breast cancer patients and is involved in the proliferation and invasion of breast cancer cells by regulating the cell cycle and microtubule stability(2017)44 cited
- → Dynamic Hyaluronic Acid Hydrogels for Comprehensively Regulating Inflammation, Angiogenesis, and Metabolism to Effectively Proheal Diabetic Wounds(2024)16 cited
- → Controlled Block Polypeptide Composed of d-Type Amino Acids: A Therapeutics Delivery Platform to Inhibit Biofilm Formation of Drug-Resistant Bacteria(2020)14 cited
- → Nakamurella flava sp. nov., a novel endophytic actinobacterium isolated from Mentha haplocalyx Briq.(2019)10 cited
- → Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer Therapy(2023)10 cited
- → Brachybacterium halotolerans sp. nov., a halotolerant, endophytic actinomycete isolated from branch of Bruguiera gymnoirhiza(2021)9 cited
- → Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo(2023)8 cited
- → Nocardioides acrostichi sp. nov., a novel endophytic actinobacterium isolated from leaf of Acrostichum aureum(2021)8 cited